O
TTOO

OppenheimerFunds’s T2 Biosystems, Inc TTOO Stock Holding History

OppenheimerFunds’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$97K Buy
+7
New +$119K ﹤0.01% 1738

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds's TTOO Position: Q1 2019 in Review

OppenheimerFunds opened a new position in T2 Biosystems, Inc (TTOO) in Q1 2019: 7 shares worth $97K. The stake represents ﹤0.01% of the portfolio and ranks #1738 among its holdings.

71 funds tracked by Wall St. Rank hold TTOO as of Q1 2019.

  • OppenheimerFunds held 7 shares of T2 Biosystems, Inc worth $97K as of Q1 2019.
  • T2 Biosystems, Inc was a new OppenheimerFunds position in Q1 2019.
  • T2 Biosystems, Inc made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1738 holding.
  • 71 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.